Demetrix

Activities: Ingredients

Trending Articles

  1. Coty’s share price surges following report of a potential sale A rumoured sale could see the Rimmel and CoverGirl owner’s luxury and mass divisions hived off to different buyers
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Huda Beauty and Rimmel London are proving that music is the next beauty frontier Huda Kattan’s cosmetics brand, L’Oréal’s Kiehl’s and Coty’s Rimmel London are among the beauty business tapping into music to solidify their brands and products in...
  3. e.l.f. Beauty and Pinterest create AI-powered beauty tool to ‘democratise’ colour analysis ‘Color e.l.f.nalysis’ will help users discover shades that match with their individual colour story, before leading them to a curated board of shoppable e.l.f. Beauty...
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Exclusive: Estée Lauder Companies UK&I appoints VP & General Manager, Makeup & Artistry Cluster Sara Staniford will steer the beauty giant’s UK and Ireland Makeup & Artistry Cluster, which comprises MAC Cosmetics, Bobbi Brown and Too Faced
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    REN Skincare closure lesson: why beauty giants must bring scrappy indie agencies into the M&A mix Following Ren Skincare’s closure this year, consultant Viola Levy argues why beauty conglomerates need to pay attention not just to indie brands, but to those indie agencies...

Upcoming event

Sun Protection Conference

24-25 June 2025 | London, UK See all

Related Content

Ingredients

Cosmetics Business in conversation with Demetrix

The leading Berkeley, California-based, biotechnology company discusses the future of cannabinoids in personal care
Ingredients

Demetrix and Evonik sign supply agreement for cannabinoids

Partnership introduces bioactives to global beauty and personal care markets
Manufacturing

Demetrix initiates 2022 commercial manufacturing campaign

Demetrix has progressed its cannabinoid production from proof of concept to commercial scale to support sales in a little over three years
Subscribe now